GLS and renal cell carcinoma: The patient had a history of RCC, splenic and mesenteric vein thrombosis, hyperlipidemia, and hypothyroidism and was previously treated with sunitinib, pazopanib, nivolumab, and an experimental glutaminase inhibitor.